A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

Not Applicable

• Conditions: Kallmann Syndrome

• Registration Number: NCT00623116
• Lead Sponsor: Hospital for Children and Adolescents, Finland

Brief Summary

Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.

Detailed Description

Kallmann syndrome is comprised of idiopathic hypogonadotropic hypogonadism and anosmia (inability to smell). Associated phenotypes may include cryptorchidism, microphallus, bone deformations, mirror movements, hearing loss and infertility. Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.

Study Timeline

• Study Start: 2007-12
• Status Verified: 2008-01
• Study First Submitted: 2008-01-11
• Study First Submitted QC: 2008-02-13
• Last Update Submitted: 2008-02-13
• Study First Posted: 2008-02-25
• Last Update Posted: 2008-02-25
• Primary Completion: 2012-12
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: ENROLLING_BY_INVITATION
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Kallmann syndrome
• Age 15 yrs or more

Exclusion Criteria

• Severe mental retardation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Clinical features including quality of life, reversibility and genetic features of Kallmann syndrome in Finland	0, 3 mo and during subsequent F/U

Secondary Outcome Measures

Name	Time	Method
epidemiology	by 2012 (anticipated)

Trial Locations

Locations (1)

Hospital for Children and Adolescents, Helsinki University Central Hospital; 🇫🇮 Helsinki, Finland